✦ LIBER ✦

A phase II trial of intraperitoneal interleukin-2 in patients with platinum-resistant or platinum-refractory ovarian cancer

✍ Scribed by Anda M. Vlad; Raluca A. Budiu; Diana E. Lenzner; Yun Wang; Julia A. Thaller; Kelly Colonello; Peggy A. Crowley-Nowick; Joseph L. Kelley; Fredric V. Price; Robert P. Edwards

Publisher: Springer-Verlag
Year: 2009
Tongue: English
Weight: 375 KB
Volume: 59
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-009-0750-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 1b-2a study to reverse platinum re

Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer

✍ Siqing Fu; Wei Hu; Revathy Iyer; John J. Kavanagh; Robert L. Coleman; Charles F. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 1 views

A phase II study of capecitabine in the

A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial

✍ Carmela Pisano; Alessandro Morabito; Roberto Sorio; Enrico Breda; Rossella Lauri 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 303 KB

Phase II trial of carboplatin and infusi

Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer

✍ Robert J. Morgan; Timothy W. Synold; David Gandara; Franco Muggia; Sidney Scudde 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 215 KB

A Phase 2 trial of the liposomal DACH pl

A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer

✍ Tomislav Dragovich; David Mendelson; Sandra Kurtin; Kelly Richardson; Daniel Von 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 302 KB

Role of salvage chemotherapy with topote

Role of salvage chemotherapy with topotecan and cisplatin in patients with paclitaxel- and platinum-resistant recurrent ovarian or primary peritoneal cancer: A phase II pilot study

✍ Ghamande, Sharad A.; Piver, M. Steven 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 2 views

## Background and Objectives: We assessed the role of salvage chemotherapy with topotecan and cisplatin in patients with platinum-and paclitaxel-resistant advanced and recurrent ovarian or primary peritoneal cancer, based on the reported in vivo and in vitro synergism between these two drugs. Meth

A phase 1 and pharmacodynamic study of d

A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer

✍ Fang Fang; Curt Balch; Jeanne Schilder; Timothy Breen; Shu Zhang; Changyu Shen; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 2 views

## Abstract ## BACKGROUND: Aberrant DNA methylation is a hallmark of cancer, and DNA methyltransferase inhibitors have demonstrated clinical efficacy in hematologic malignancies. On the basis of preclinical studies indicating that hypomethylating agents can reverse platinum resistance in ovarian c